Antigen ny-co-1

Immunohistochemistry (Paraffin) (1:50-1:200), Western Blot (1:500-1:1000)

Serologically defined colon cancer antigen 1 homolog; Serologically defined colon cancer antigen 1; Antigen NY-CO-1

Western Blot (1:500-1:1000)

Serologically defined colon cancer antigen 1 homolog; Serologically defined colon cancer antigen 1; Antigen NY-CO-1

Western Blot (1:500-1:3000)

Antigen NY-CO-3

Western Blot (1:500-1:1000)

StAR-related lipid transfer protein 10; Serologically defined colon cancer antigen 28 homolog; START domain-containing protein 10; Serologically defined colon cancer antigen 28; Antigen NY-CO-28

Western Blot (1 ug/ml)

STIP1 homology and U box-containing protein 1; Carboxy terminus of Hsp70-interacting protein; CLL-associated antigen KW-8; Antigen NY-CO-7; E3 ubiquitin-protein ligase CHIP

Immunofluorescence (1:50-1:200), Immunohistochemistry (Paraffin) (1:50-1:200), Western Blot (1:500-1:1000)

Heat shock 110 kDa protein; Antigen NY-CO-25; Heat shock-related 100 kDa protein E7I; 42 degrees C-HSP

Western Blot (1:500-1:3000)

StAR-related lipid transfer protein 10; Serologically defined colon cancer antigen 28 homolog; START domain-containing protein 10; Serologically defined colon cancer antigen 28; Antigen NY-CO-28

Immunohistochemistry (Paraffin) (1:100-1:1000), Western Blot (1:5000-1:20,000)

STIP1 homology and U box-containing protein 1; Carboxy terminus of Hsp70-interacting protein; CLL-associated antigen KW-8; Antigen NY-CO-7

Western Blot (1:500-1:3000)

Centrosomal colon cancer autoantigen protein; Antigen NY-CO-8

Immunocytochemistry (1:1000-1:10,000), Immunofluorescence (1:1000-1:10,000)

Centrosomal colon cancer autoantigen protein; Antigen NY-CO-8

Immunofluorescence (1:50-1:200), Immunohistochemistry (Paraffin) (1:50-1:200), Western Blot (1:500-1:1000)

Antigen NY-CO-9

Western Blot (1:500-1:1000)

Serologically defined colon cancer antigen 43; Protein kinase with no lysine 2; Protein kinase lysine-deficient 2; Antigen NY-CO-43

Immunohistochemistry (Paraffin) (1:50-1:100), Western Blot (1:500-1:1000)

Antigen NY-CO-9; MEF2-interacting transcription repressor MITR; Histone deacetylase-related protein; Histone deacetylase 7B

Western Blot (1:500-1:3000)

Serologically defined colon cancer antigen 33; Antigen NY-CO-33

Western Blot (1:500-1:2000)

Antigen NY-CO-9; MEF2-interacting transcription repressor MITR; Histone deacetylase-related protein; Histone deacetylase 7B

Western Blot (1:500-1:1000)

Serologically defined colon cancer antigen 16; Antigen NY-CO-16; Juvenile spermatogonial depletion-like X-linked protein

Immunocytochemistry (2.5 ug/mL), Immunofluorescence (2.5 ug/mL), Western Blot (1 ug/mL)

Serologically defined colon cancer antigen 33; Antigen NY-CO-33; Serologically defined colon cancer antigen 3 homolog

Western Blot (1:500-1:1000)

Antigen NY-CO-9

Immunohistochemistry (Paraffin) (1:50-1:100), Western Blot (1:500-1:1000)

Antigen NY-CO-9

ChIP assay (1-3 ul), Immunoprecipitation (1:50), Western Blot (1:1000)

Histone deacetylase 7A; Antigen NY-CO-9

Immunocytochemistry (1:100-1:1000), Immunofluorescence (1:100-1:1000), Immunohistochemistry (Paraffin) (1:100-1:1000), Western Blot (1:500-1:3000)

STIP1 homology and U box-containing protein 1; Carboxy terminus of Hsp70-interacting protein; CLL-associated antigen KW-8; Antigen NY-CO-7

Immunohistochemistry (1:50-1:100), Western Blot (1:1000)

STIP1 homology and U box-containing protein 1; Carboxy terminus of Hsp70-interacting protein; CLL-associated antigen KW-8; Antigen NY-CO-7

ELISA (1:32,000), Immunohistochemistry (Paraffin) (Assay-dependent), Western Blot (1-3 µg/ml)

Usher syndrome type-1C protein homolog; Usher syndrome type-1C protein; Renal carcinoma antigen NY-REN-3; Protein PDZ-73; Autoimmune enteropathy-related antigen AIE-75; Antigen NY-CO-38/NY-CO-37; PDZ domain-containing protein

ChIP assay (1-3 µg x 10^6 cells), Immunocytochemistry (2µg/ml), Immunofluorescence (2µg/ml), Immunohistochemistry (Paraffin) (1-2 µg/ml), Western Blot (1-2 µg/ml)

Tumor suppressor p53; Phosphoprotein p53; Antigen NY-CO-13

Flow Cytometry (1:10-1:50), Immunohistochemistry (1:50-1:100), Western Blot (1:1000)

Heat shock 110 kDa protein; Antigen NY-CO-25

ChIP assay (1:10-1:500), Immunoprecipitation (1:10-1:500), Western Blot (1-3 µg/ml)

Antigen NY-CO-9

Western Blot (0.3-1 ug/ml)

STIP1 homology and U box-containing protein 1; Carboxy terminus of Hsp70-interacting protein; CLL-associated antigen KW-8; Antigen NY-CO-7

Flow Cytometry (1:10-1:50), Western Blot (1:1000)

STIP1 homology and U box-containing protein 1; Carboxy terminus of Hsp70-interacting protein; CLL-associated antigen KW-8; Antigen NY-CO-7

Western Blot (1:1000)

p51-nox; P67phox-like factor; NCF2-like protein; Antigen NY-CO-31

ChIP assay (1-3 µg x 10^6 cells), Immunohistochemistry (Paraffin) (Assay-Dependent), Immunoprecipitation (Assay-Dependent), Western Blot (Assay-Dependent)

Tumor suppressor p53; Phosphoprotein p53; Antigen NY-CO-13